Browse > Article
http://dx.doi.org/10.6116/kjh.2013.28.1.83.

Effect of Tetramethylpyrazine on Pro-Inflammatory Cytokine Expressions in Mouse Brain Tissue following Intracerebroventricular Lipopolysaccharide Treatment  

Choi, Yong-Seok (Department of Oriental Medical Science, Graduate School of East-West Medical Science, Kyung Hee University)
Won, Jong-Woo (Department of Oriental Medical Science, Graduate School of East-West Medical Science, Kyung Hee University)
Yoo, Inwoo (Department of Oriental Medical Science, Graduate School of East-West Medical Science, Kyung Hee University)
Shin, Jung-Won (Department of Oriental Medical Science, Graduate School of East-West Medical Science, Kyung Hee University)
Kim, Seong-Joon (Department of Oriental Medical Science, Graduate School of East-West Medical Science, Kyung Hee University)
Sohn, Nak-Won (Department of Oriental Medical Science, Graduate School of East-West Medical Science, Kyung Hee University)
Publication Information
The Korea Journal of Herbology / v.28, no.1, 2013 , pp. 83-90 More about this Journal
Abstract
Objectives : Tetramethylpyrazine (TMP) is an active ingredient in Ligusticum wallichii and has a wide range of neuroprotection effects. This study investigated anti-neuroinflammatory effect of TMP on brain regions in intracerebroventricular (i.c.v.) lipopolysaccharide (LPS)-treated C57BL/6 mice. Methods : TMP was administered intraperitoneally at doses of 10, 20, and 30 mg/kg at 1 h prior to LPS (3 mg/kg) i.c.v. injection. mRNA level of pro-inflammatory cytokines, including tumor necrosis factor-${\alpha}$ (TNF-${\alpha}$), interleukin (IL)-$1{\beta}$ and IL-6, was measured in the cerebral cortex, hippocampus, and hypothalamus tissue using real-time polymerase chain reaction at 24 h after the LPS injection. Cyclooxygenase-2 (COX-2) positive cells in the hypothalamus was also observed using immunohistochemistry at 24 h after the LPS injection. Results : At a dose of 30 mg/kg TMP significantly attenuated up-regulation of TNF-${\alpha}$ and IL-$1{\beta}$ mRNA in the cerebral cortex and IL-$1{\beta}$ mRNA in the hippocampus. In the hypothalamus, doses of 20 mg/kg and 30 mg/kg TMP significantly attenuated up-regulation of TNF-${\alpha}$, IL-$1{\beta}$, and IL-6 mRNA induced by the LPS injection. In addition, TMP (30 mg/kg) significantly reduced the number of COX-2 positive cells in the hypothalamus. Conclusion : These results indicate that TMP has an anti-inflammatory effect on neuroinflammation, especially in the hypothalamus, induced by LPS i.c.v. injection and suggest that TMP-containing Ligusticum wallichii may play a modulatory role on the systemic responses following hypothalamic inflammation.
Keywords
Ligusticum wallichii; Tetramethylpyrazine; Neuroinflammation; Pro-inflammatory cytokine; Hypothalamic inflammation;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Cai D, Liu T. Hypothalamic inflammation: a double-edged sword to nutritional diseases. Ann NY Acad Sci. 2011 ; 1243 : E1-39.   DOI   ScienceOn
2 Granger JI, Ratti PL, Datta SC, Raymond RM, Opp MR. Sepsis-induced morbidity in mice: Effects on body temperature, body weight, cage activity, social behavior and cytokines in brain. Psychoneuroendocrinology. 2012 ; doi :10.1016/j.psyneuen.2012.10.010.   DOI   ScienceOn
3 Harden LM, du Plessis I, Roth J, Loram LC, Poole S, Laburn HP. Differences in the relative involvement of peripherally released interleukin (IL)-6, brain IL-$1\beta$ and prostanoids in mediating lipopolysaccharide-induced fever and sickness behavior. Psychoneuroendocrinology. 2011 ; 36 : 608-22.   DOI   ScienceOn
4 Mancuso C, Navarra P, Preziosi P. Roles of nitric oxide, carbon monoxide, and hydrogen sulfide in the regulation of the hypothalamic-pituitary-adrenal axis. J Neurochem. 2010 ; 113 : 563-75.   DOI   ScienceOn
5 Grinevich V, Ma XM, Herman JP, Jezova D, Akmayev I, Aguilera G. Effect of repeated lipopolysaccharide administration on tissue cytokine expression and hypothalamic-pituitary-adrenal axis activity in rats. J Neuroendocrinol. 2001 ; 13 : 711-23.   DOI   ScienceOn
6 Kim HC. Herbal Pharmacology. Seoul Gipmoon-Dang. 2001 : 318-20.
7 Choi SH, Aid S, Bosetti F. The distinct roles of cyclooxygenase-1 and –2 in neuroinflammation: implications for translational research. Trends Pharmacol Sci. 2009 ; 30 : 174-81.   DOI   ScienceOn
8 Zheng CY, Xiao W, Zhu MX, Pan XJ, Yang ZH, Zhou SY. Inhibition of cyclooxygenase-2 by tetramethylpyrazine and its effects on A549 cell invasion and metastasis. Int J Oncol. 2012 ; 40 : 2029-37.
9 He X, Zheng Z, Yang X, Lu Y, Chen N, Chen W. Tetramethylpyrazine attenuates PPAR-$\gamma$ antagonist-deteriorated oxazolone-induced colitis in mice. Mol Med Report. 2012 ; 5 : 645-50.
10 Liang SD, Gao Y, Xu CS, Xu BH, Mu SN. Effect of tetramethylpyrazine on acute nociception mediated by signaling of P2X receptor activation in rat. Brain Res. 2004 ; 995 : 247-52.   DOI   ScienceOn
11 Li SY, Jia YH, Sun WG, Tang Y, An GS, Ni JH, Jia HT.Stabilization of mitochondrial function by tetramethylpyrazine protects against kainateinduced oxidative lesions in the rat hippocampus. Free Radic Biol Med. 2010 ; 48 : 597-608.   DOI   ScienceOn
12 Sternberg EM. Neural-immune interactions in health and disease. J Clin Invest. 1997 ; 100 : 2641–7.   DOI   ScienceOn
13 Rosenberg PB. Clinical aspects of inflammation in Alzheimer's disease. Int Rev Psychiatry. 2005 ; 17 : 503-14.   DOI   ScienceOn
14 Shih YH, Wu SL, Chiou WF, Ku HH, Ko TL, Fu YS. Protective effects of tetramethylpyrazine on kainate-induced excitotoxicity in hippocampal culture. Neuroreport. 2002 ; 13 : 515-9.   DOI   ScienceOn
15 Zhang Z, Wei T, Hou J, Li G, Yu S, Xin W.Iron-induced oxidative damage and apoptosis in cerebellar granule cells: attenuation by tetramethylpyrazine and ferulic acid. Eur J Pharmacol. 2003 ; 467 : 41-7.   DOI   ScienceOn
16 Cheng XR, Zhang L, Hu JJ, Sun L, Du GH. Neuroprotective effects of tetramethylpyrazine on hydrogen peroxide-induced apoptosis in PC12 cells. Cell Biol Int. 2007 ; 31 : 438-43.   DOI   ScienceOn
17 Liao SL, Kao TK, Chen WY, Lin YS, Chen SY, Raung SL, Wu CW, Lu HC, Chen CJ. Tetramethylpyrazine reduces ischemic brain injury in rats. Neurosci Lett. 2004 ; 372 : 40-5.   DOI   ScienceOn
18 Kao TK, Ou YC, Kuo JS, Chen WY, Liao SL, Wu CW, Chen CJ, Ling NN, Zhang YH, Peng WH. Neuroprotection by tetramethylpyrazine against ischemic brain injury in rats. Neurochem Int. 2006 ; 48 : 166-76.   DOI   ScienceOn
19 Szelenyi J. Cytokines and the central nervous system. Brain Res Bull. 2001 ; 54 : 329-38.   DOI   ScienceOn
20 Banks WA, Kastin AJ. Relative contributions of peripheral and central sources to levels of IL-1 alpha in the cerebral cortex of mice: Assessment with species-specific enzyme immunoassays. J Neuroimmunol. 1997 ; 79 : 22-8.   DOI   ScienceOn
21 Hsiao G, Chen YC, Lin JH, Lin KH, Chou DS, Lin CH, Sheu JR. Inhibitory mechanisms of tetramethylpyrazine in middle cerebral artery occlusion (MCAO)-induced focal cerebral ischemia in rats. Planta Med. 2006 ; 72 : 411-7.   DOI   ScienceOn
22 Yang J, Li J, Lu J, Zhang Y, Zhu Z, Wan H. Synergistic protective effect of astragaloside IV-tetramethylpyrazine against cerebral ischemic-reperfusion injury induced by transient focal ischemia. J Ethnopharmacol. 2012 ; 140 : 64-72.   DOI   ScienceOn
23 Chang Y, Hsiao G, Chen SH, Chen YC, Lin JH, Lin KH, Chou DS, Sheu JR. Tetramethylpyrazine suppresses HIF-1alpha, TNF-alpha, and activated caspase-3 expression in middle cerebral artery occlusion-induced brain ischemia in rats. Acta Pharmacol Sin. 2007 ; 28 : 327-33.   DOI   ScienceOn
24 Zhu XL, Xiong LZ, Wang Q, Liu ZG, Ma X, Zhu ZH, Hu S, Gong G, Chen SY. Therapeutic time window and mechanism of tetramethylpyrazine on transient focal cerebral ischemia/ reperfusion injury in rats. Neurosci Lett. 2009 ; 449 : 24-7.   DOI   ScienceOn
25 Xiao X, Liu Y, Qi C, Qiu F, Chen X, Zhang J, Yang P. Neuroprotection and enhanced neurogenesis by tetramethylpyrazine in adult rat brain after focal ischemia. Neurol Res. 2010 ; 32 : 547-55.   DOI   ScienceOn
26 Sun Y, Yu P, Zhang G, Wang L, Zhong H, Zhai Z, Wang L, Wang Y. Therapeutic effects of tetramethylpyrazine nitrone in rat ischemic stroke models. J Neurosci Res. 2012 ; 90 : 1662-9.   DOI   ScienceOn
27 Tang Q, Han R, Xiao H, Shen J, Luo Q, Li J. Neuroprotective effects of tanshinone IIA and/or tetramethylpyrazine in cerebral ischemic injury in vivo and in vitro. Brain Res. 2012 ; 1488 : 81-91.   DOI   ScienceOn
28 Gao C, Liu X, Liu W, Shi H, Zhao Z, Chen H, Zhao S. Anti-apoptotic and neuroprotective effects of Tetramethylpyrazine following subarachnoid hemorrhage in rats. Auton Neurosci. 2008 ; 141 : 22-30.   DOI   ScienceOn
29 Fan LH, Wang KZ, Cheng B, Wang CS, Dang XQ. Anti-apoptotic and neuroprotective effects of Tetramethylpyrazine following spinal cord ischemia in rabbits. BMC Neurosci. 2006 ; 7 : 48.   DOI
30 Liang Y, Yang QH, Yu XD, Jiang DM. Additive effect of tetramethylpyrazine and deferoxamine in the treatment of spinal cord injury caused by aortic cross-clamping in rats. Spinal Cord. 2011 ; 49 : 302-6.   DOI   ScienceOn
31 Fan L, Wang K, Shi Z, Die J, Wang C, Dang X. Tetramethyl- pyrazine protects spinal cord and reduces inflammation in a rat model of spinal cord ischemia-reperfusion injury. J Vasc Surg. 2011 ; 54 : 192-200.   DOI   ScienceOn
32 Hu JZ, Huang JH, Xiao ZM, Li JH, Li XM, Lu HB. Tetramethyl- pyrazine accelerates the function recovery of traumatic spinal cord in rat model by attenuating inflammation. J Neurol Sci. 2013 ; 324 : 94-9.   DOI   ScienceOn
33 Fu X, Zunich SM, O'Connor JC, Kavelaars A, Dantzer R, Kelley KW. Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures. J Neuroinflammation. 2010 ; 7 : 43.   DOI   ScienceOn
34 Harry GJ, Kraft AD. Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment. Expert Opin Drug Metab Toxicol. 2008 ; 4 : 1265-77.   DOI   ScienceOn
35 Konat GW, Kielian T, Marriott I. The role of Toll-like receptors in CNS response to microbial challenge. J Neurochem. 2006 ; 99 : 1–12.
36 Qin L, Wu X, Block ML, Liu Y, Breese GR, Hong JS, Knapp DJ, Crews FT. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 2007 ; 55 : 453-62.   DOI   ScienceOn
37 Jeong HK, Jou I, Joe EH. Systemic LPS administration induces brain inflammation but not dopaminergic neuronal death in the substantia nigra. Exp Mol Med. 2010 ; 42 : 823-32.   DOI   ScienceOn